CS
HSTO

Credit Suisse’s Histogen Inc. Common Stock HSTO Stock Holding History

Credit Suisse’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-88
Closed -$97K – 4276
2017
Q3 		$97K Buy
+88
New +$100K ﹤0.01% 4097
2016
Q4 		– Sell
-195
Closed -$78K – 4283
2016
Q3 		$78K Buy
+195
New +$79.5K ﹤0.01% 3965
2015
Q1 		– Sell
-106
Closed -$149K – 4644
2014
Q4 		$149K Buy
+106
New +$153K ﹤0.01% 4356

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Credit Suisse's HSTO Position: Q4 2017 in Review

Credit Suisse sold out of Histogen Inc. Common Stock (HSTO) in Q4 2017, closing a stake of 88 shares — an estimated $97K sold.

Credit Suisse first reported a position in HSTO in Q4 2014 and held it in 3 quarters. The position peaked at $149K in Q4 2014. 70 funds tracked by Wall St. Rank hold HSTO as of Q4 2017.

  • Credit Suisse reported no remaining Histogen Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Credit Suisse sold 88 Histogen Inc. Common Stock shares in Q4 2017, an estimated $97K.
  • Credit Suisse first reported a position in Histogen Inc. Common Stock in Q4 2014 and held it in 3 quarters.
  • Credit Suisse's Histogen Inc. Common Stock position peaked at $149K in Q4 2014.
  • 70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2017.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.